As elucidated in the preamble, preterm births (PTB) pertains to birth that occurs before 37 weeks of gestation, a definition that the World Health Organization has endorsed. Premature births accounted for 11.1% of all deliveries in 2010, accounting for 14.9 million births worldwide. Preterm birth accounts for about 5% of births in European countries and approximately 18% in African countries. Children born prematurely have an augmented risk of mortality before their fifth year of life. The financial burden of neonatal intensive care is substantial, and its emotional toll on families can last for years ^[1][2][1,5].

The deposition of paternal antigens on fetal tissues relies on feto-maternal immunological tolerance, as shown in a number of studies. The uterus is invaded by fetal trophoblast cells. During first contact with seminal fluid during copulation, the mother’s immune system recognizes and reacts to fetal or paternal antigens; this process is repeated several times throughout pregnancy. By stimulating the production of proinflammatory cytokines and the recruitment of leukocytes to the uterine lining, the inclusion of cytokines, chemokines and prostaglandins in seminal fluid makes implantation itself an inflamed process. This inflammation must subside, and a tolerogenic environment must be developed around the time of implantation ^[2][3][5,6].

Among the many processes set in motion to create this tolerogenic setting are the release of anti-inflammatory chemicals such as TGF and the generation of specialist anti-inflammatory T cells designated as CD4+FOXP3+ regulatory T (Treg) cells, which restrain anti-fetal inflammatory immune responses ^[4][5][6][7,8,9]. Tolerogenic dendritic cells (DCs), which are only found in the decidua, play a crucial role in forming regulatory T cells (Tregs) by cross-presenting fetal antigens to maternal CD4+ T cells. In a two-way street of immunomodulation, regulatory T cells (Tregs) engage with dendritic cells (DCs) and macrophages (M) to induce tolerogenic phenotypes in both cell types. By preventing T effector (Teff) cell responses and maintaining anergy in the pool of T conventional (Tcon) cells that would otherwise grow into Teff cells, Treg cells play a vital role in immunological defense against anti-fetal reactions. Furthermore, placental cells contribute to a tolerogenic microenvironment by increasing operationally repressive CD4+FOXP3+ Treg cells and restricting the stimulation of T helper (Th)1-, Th17- and Th2cytokine-producing Teff cells ^[7][8][9][10,11,12]. These cytokines are released by placental cells in addition to IL-10 and trophoblast-derived colony-stimulating factor (CSF)1 (formerly M-CSF) ^{[4][5][6][7][8][9][10][11][12][13]}[7,8,9,10,11,12,13,14,15,16].

2. Immuno-Inflammation and Preterm Birth

What sets apart term and preterm labor could be an early imbalance of decidual inflammatory signals or a powerful aberrant stimulation (internal or external) that initiates inflammatory pathways. Anti-inflammatory mediators (including IL-10 and IL-4), in contrast to proinflammatory mediators (IL-1, IL-6, IL-8, TNF- and INF-), are downregulated in PTB ^[14][15][32,33]. In actuality, IL-10 has a major impact on preterm birth; it is generally thought of as a cytokine that helps keep the neonate inside the uterus. The symptoms of PTB syndrome are placental malfunction, early uterine contractions, membrane rupture and cervical dilatation. Additionally, myometrial, cervical, endometrial, decidual and placental pathology have all been linked to PTB ^[16][17][34,35]. Placental lesions indicative of maternal vascular under-perfusion are seen in approximately 30% of patients with PTB. Therefore, PTB may be considered a disorder similar to preeclampsia induced by defective deep placentation ^[18][19][36,37]. Furthermore, how a mother handles stress, infections and her diet impacts her developing child’s immune system, leading to impaired immune tolerance and an inflammatory response. Bacterial flora in the placenta is similar to that found in the mouth rather than the vagina. Inflammation and infection have been tied to as much as one-fourth of all preterm births. The unique triple “I” approach, which represents intrauterine inflammation, infection or both, emphasizes the fact that intrauterine inflammation can manifest itself in the absence of overtly harmful intrauterine infection. Furthermore, women with a short cervix are more likely to experience sterile intra-amniotic inflammation (10%) than microbial-associated intra-amniotic inflammation ^[20][38]. Despite this, both trigger the same cytokine mediators. It has been found that IL-6 and IL-1β are the two most essential uterine mediators throughout the transition period. High amounts of IL-6 are present at the start of labor, suggesting that it plays a role in implantation, pregnancy and birth. It is also implicated in stimulating amnion and decidual cells, culminating in increased prostaglandin production ^[21][22][39,40]. In addition, IL-6 in vaginal fluid has been extensively studied as a diagnostic biomarker of preterm delivery. There is a correlation between IL-6 levels, a marker of inflammation, and perinatal death and morbidity ^[18][21][36,39]. However, amniotic fluid IL-6 as a diagnostic marker for intraamniotic inflammation has been criticized by some researchers, who contend that this method fails to capture the full scope of intrauterine inflammation. Nonetheless, IL-1β affects the regulation of genes involved in inflammation and labor in the uterus. Furthermore, IL-1 promotes progesterone (P4) withdrawal by elevating nuclear progesterone receptor A, and it is a powerful activator of prostaglandin production by inducing COX2 ^[17][35]. In addition, IL-1-related pathways are elevated throughout the third trimester of pregnancy in women who give birth prematurely ^[18][21][36,39]. PTB is linked to increased choriodecidual inflammation, as well as increased M1 macrophages and NK cells when viewed from the scope of cells. PAMPs (infectious stimuli) or DAMPs (sterile stimuli) are two possible ways that a detrimental state can activate the innate system. The stress-exposed uterus, the developing fetus or the aging placenta can all release DAMPs. Some researchers have revealed that cfDNA triggers sterile inflammation and that fetal membrane aging is a crucial indicator at the commencement of labor. As a result of this innate stimulation, TLRs are activated, which in turn activate the production of proinflammatory cytokines, chemokines and leukocytes, ultimately resulting in the initiation of labor. Spontaneous PTB occurs if the deregulation of decidual inflammatory signaling occurs at an early stage. Mid-trimester endometrium inflammation, triggered by factors such as intrauterine infection or placental abruption, has also been linked to PTB. Moreover, smoking, anemia, a short cervix, a history of genital tract infections, racial/ethnic background and low or high birth weight may all be indicators of a lack of protective immunity inside the uterine tissues ^[17][18][35,36]. Genetic predisposition has been linked to PTB because it clusters in families, is highly heritable, can be identified through genetic susceptibility markers and reveals racial disparities. Women born prematurely have an increased risk of having premature kids in the future. Furthermore, at least one-third of PTB can be attributed to genetics, according to twin studies. An examination of maternal data revealed an upregulation of innate immunity-related genes and a downregulation of adaptive immunity-related genes, among the 210 genes shown to be differently expressed in PTB. Among these genes, 18 showed trimester-specific expression differences (mostly during the second trimester). It was discovered that the immune-related proteins IL-1R1 and tissue factor pathway inhibitor are differentially expressed and released longitudinally ^[19][20][37,38]. As a result, PTB has a polygenic foundation, meaning that it is caused by uncommon mutations or harmful variations in several genes associated with innate immunity and host defense systems against microorganisms and their toxic materials. Thus, inflammatory genes are activated and accelerate these processes. Furthermore, there are inherited polymorphisms that modify the inflammatory response in PTB, and there are identity genetic variations that alter the inflammatory response in PTB. TLR5, for example, is increased in the mother but downregulated in the fetus, a finding that is consistent with other recent studies. Epigenetic changes or variations due to incorrect fetal programming have also been linked to adult-onset illnesses in preterm infants ^{[21][22][23][24][25]}[39,40,41,42,43]. Hormones that stimulate labor and reproduction inflammatory responses during pregnancy are aided by gestational hormones. For example, estrogen suppresses proinflammatory cytokines (IL-1; TNF-α; IFN-γ) and promotes anti-inflammatory IL-10, IL-4 and TGF-β. Nonetheless, IL-10 has been regarded as part of a pro-labor inflammatory response, playing a role in labor that varies with the tissue involved and can be either active or tolerant. Anti-inflammatory progesterone also helps stop uterine contractions and shields the developing fetus from harm. However, peripheral progesterone levels in humans are remarkable in that they do not fluctuate during pregnancy and only decrease after the baby and placenta have been delivered. In the last weeks of pregnancy, serum P4 levels rise, but the hormone’s ability to sustain a pregnancy weakens. This suggests that variations in labor may be attributable to the expression of nPRs (nuclear progesterone receptors) A and B. The primary receptor, nPRB, has anti-inflammatory properties that delay or stop labor and delivery ^[26][27][28][44,45,46].